Keybank National Association OH Raises Stock Position in MetLife, Inc. $MET

Keybank National Association OH increased its position in shares of MetLife, Inc. (NYSE:MET) by 8.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 75,695 shares of the financial services provider’s stock after acquiring an additional 5,841 shares during the period. Keybank National Association OH’s holdings in MetLife were worth $5,353,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Norges Bank purchased a new position in shares of MetLife during the 4th quarter valued at $639,986,000. Vanguard Group Inc. boosted its stake in MetLife by 12.1% during the fourth quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock valued at $5,727,518,000 after buying an additional 7,805,814 shares during the period. Pzena Investment Management LLC boosted its stake in MetLife by 22.9% during the fourth quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock valued at $938,071,000 after buying an additional 2,211,315 shares during the period. AQR Capital Management LLC grew its position in MetLife by 105.3% during the third quarter. AQR Capital Management LLC now owns 3,305,620 shares of the financial services provider’s stock worth $271,424,000 after buying an additional 1,695,563 shares in the last quarter. Finally, First Trust Advisors LP increased its stake in MetLife by 173.4% in the 3rd quarter. First Trust Advisors LP now owns 1,641,253 shares of the financial services provider’s stock worth $135,190,000 after acquiring an additional 1,040,894 shares during the last quarter. 94.99% of the stock is owned by institutional investors.

MetLife Trading Down 0.2%

MET stock opened at $89.90 on Friday. The company has a market capitalization of $57.84 billion, a PE ratio of 17.42, a price-to-earnings-growth ratio of 0.68 and a beta of 0.78. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.20 and a current ratio of 0.20. MetLife, Inc. has a one year low of $67.33 and a one year high of $90.06. The company’s 50 day moving average price is $83.11 and its two-hundred day moving average price is $78.34.

MetLife (NYSE:MET) last released its earnings results on Wednesday, May 6th. The financial services provider reported $2.42 EPS for the quarter, beating the consensus estimate of $2.27 by $0.15. The company had revenue of $14.18 billion for the quarter, compared to analyst estimates of $19.49 billion. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.96 EPS. As a group, analysts predict that MetLife, Inc. will post 9.98 earnings per share for the current fiscal year.

MetLife Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 9th. Investors of record on Tuesday, May 12th were issued a dividend of $0.5925 per share. The ex-dividend date was Tuesday, May 12th. This represents a $2.37 annualized dividend and a yield of 2.6%. This is a boost from MetLife’s previous quarterly dividend of $0.57. MetLife’s dividend payout ratio (DPR) is currently 45.93%.

Analyst Upgrades and Downgrades

MET has been the topic of several recent analyst reports. Morgan Stanley raised their price target on MetLife from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Thursday, May 21st. Mizuho set a $95.00 price objective on shares of MetLife in a research report on Friday, May 8th. TD Cowen lowered their target price on shares of MetLife from $91.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, March 11th. Bank of America dropped their target price on shares of MetLife from $103.00 to $99.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Finally, UBS Group boosted their price target on shares of MetLife from $98.00 to $102.00 and gave the stock a “buy” rating in a research note on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, MetLife has an average rating of “Moderate Buy” and a consensus price target of $95.62.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.